News & Highlights

NEW CSRxP ANALYSIS: BIG PHARMA SPENDS THREE TIMES MORE ON PROFITS, ADVERTISING AND OVERHEAD THAN R&D

Sep 2, 2026

Breaking Down The “Big Pharma Dollar” Shows Brand Name Pharmaceutical Read More

ICYMI: NEW REPORT OUTLINES MERCK’S STRATEGY TO BLOCK COMPETITION, KEEP PRICES HIGH ON BLOCKBUSTER CANCER DRUG KEYTRUDA

Apr 15, 2026

Big Pharma Giant Engages in Product Hopping Strategy to Game the Patent Read More

ICYMI: FDA GUIDANCE PROMOTES ACCELERATED BIOSIMILAR DEVELOPMENT AND COMPETITION

Mar 11, 2026

Boosting Biosimilar Competition and Cracking Down on Big Pharma’s Egregious Read More

CSRxP ANALYSIS: PHARMACEUTICAL INDUSTRY’S PROFIT MARGINS STILL 10 TIMES GREATER THAN OTHER SECTORS OF DRUG SUPPLY CHAIN

Jan 13, 2026

New Report Underscores How Brand Name Drug Companies Ride High on Egregious Read More

ICYMI: SKINNY LABELS, BIG SAVINGS ACT INTRODUCED IN U.S. HOUSE

Dec 9, 2025

Bipartisan Solution Would Help Bring More Generics and Biosimilars to Market, Read More

ICYMI: I-MAK SURVEY FINDS FOUR IN FIVE AMERICANS SUPPORT PATENT REFORMS TO LOWER PRESCRIPTION DRUG PRICES

Nov 11, 2025

New Findings Underscore Broad-Based Support for Market-Based Solutions to Hold Read More

ICYMI: CSRxP SURVEY FINDS AMERICAN VOTERS OVERWHELMINGLY HOLD BIG PHARMA RESPONSIBLE FOR HIGH DRUG PRICES

Mar 6, 2025

Across Political Spectrum, Fabrizio Ward Finds Voters Identify Pharmaceutical Read More

CSRxP: FABRIZIO WARD SURVEY FINDS AMERICAN VOTERS OVERWHELMING HOLD BIG PHARMA COMPANIES RESPONSIBLE FOR HIGH DRUG PRICES

Feb 28, 2025

Voters Across the Political Spectrum Identify Pharmaceutical Company Profits Read More

ICYMI: INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW ANNOUNCES ANNUAL LAUNCH PRICE AND ACCESS REPORT FOR 2025

Jan 22, 2025

New Analysis Will Help Shine a Light on Big Pharma’s Increasingly Read More

ICYMI: AARP URGES PASSAGE OF PRESCRIPTION DRUG LEGISLATION BY YEAR’S END

Dec 13, 2024

AARP Urges Lawmakers to Pass Cornyn-Blumenthal On Friday, AARP urged lawmakers Read More

ICYMI: SENATOR CORNYN DELIVERS REMARKS ON U.S. SENATE PASSAGE OF PATENT THICKET CRACKDOWN

Jul 15, 2024

Lawmakers Unanimously Advance Bipartisan Solution to Help Hold Big Pharma Read More